Sławomir Ławicki

No ORCID on file · 9 papers in corpus · active 2007-2025

Study types

  • article 6

Condition tags

  • endometriosis 2
  • infertility 1
article 2025
Diagnostics ·doi:10.3390/diagnostics15111366

Background: Endometriosis is a common gynecological disease linked to significant diagnostic challenges. Cadherin 12 (CDH12), as a member of adhesion molecules, is supposed to be involved in the pathogenesis of this disease and therefore ca…

article 2025
Biomedicines ·doi:10.3390/biomedicines13092143

Background/Objectives: Endometrioid ovarian cancer (EnOC) is a late-diagnosed gynecological cancer with limited diagnostic methods that, when detected at an early stage, has a good prognosis. This study is the first to evaluate the plasma c…

article 2025
Advances in medical sciences ·doi:10.1016/j.advms.2025.11.002

PURPOSE: Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid …

2022
Cancer management and research ·doi:10.2147/cmar.s385658

Ovarian cancer is one of the most common gynecologic malignancies. It is characterized by a high mortality rate, which is mainly due to the asymptomatic course of the disease. In light of the high mortality rate and increasing morbidity, ne…

article 2018
2017
Journal of ovarian research ·doi:10.1186/s13048-017-0338-z

BackgroundMMP-7 and TIMP-1 may play a role in the pathogenesis of cancer disease. In this study we investigated plasma levels of selected metalloproteinase and its tissue inhibitor in comparison to plasma levels of the commonly accepted tum…

article 2016

Metalloproteinases (MMPs) are a family of proteolytic enzymes, involved in the degradation of collagen and other extracellular matrix components. They play a very important role in many physiological processes, i.e. angiogenesis, hemostasis…

2015
Journal of ovarian research ·doi:10.1186/s13048-015-0153-3

BackgroundWe investigated plasma levels of M-CSF and conventional tumor markers (HE4 and CA 125) in epithelial ovarian cancer patients as compared to control groups: benign ovarian tumor patients (cysts) and healthy subjects.MethodsM-CSF le…

article 2007